IFNA1 and neoplasm: DC: These are innate immune cells that have a key role in TME, as they constitute APCs, which present the tumor cells (neoantigens) to cytotoxic T cells and stimulate the recruitment of other immune cells via cytokine release and enhance the anti-tumor response via secreting IFN-α/β.